Phlebotomy has demonstrated to be useful for the sustained management of erythropoietin (EPO)-induced malignant hypertension in patients on chronic hemodialysis and post-transplant hypertension associated with erythrocytosis19,20. The gene discussed is EPO; the disease is Hypertension.